Concentrix Balance Sheet Health
Financial Health criteria checks 1/6
Concentrix has a total shareholder equity of $2.7B and total debt of $4.6B, which brings its debt-to-equity ratio to 169.7%. Its total assets and total liabilities are $10.5B and $7.8B respectively. Concentrix's EBIT is $620.7M making its interest coverage ratio 2.2. It has cash and short-term investments of $255.6M.
Key information
169.73%
Debt to equity ratio
US$4.58b
Debt
| Interest coverage ratio | 2.2x |
| Cash | US$255.57m |
| Equity | US$2.70b |
| Total liabilities | US$7.81b |
| Total assets | US$10.51b |
Recent financial health updates
No updates
Recent updates
Narrative Update • Jul 07
CNXC: Reset Expectations And Index Shift Will Support Future Upside Potential
Analysts have lowered the Concentrix fair value estimate from $41.25 to $35.25, reflecting reduced long term revenue growth assumptions. Profit margin expectations and the future P/E input also shift in response to updated models following recent Q2 results and guidance.Seeking Alpha • Jun 30
Concentrix: I'm Not Buying The Dip Following Weak Q2 Earnings
Summary The market fears that Concentrix Corporation faces existential AI disruption, though the company's operating results have been resilient. That said, the earnings trajectory has started to weaken a bit, and Q2 was another underwhelming report. Shares would be a value here if the company had a clean balance sheet. But, due to its massive leverage, this is a highly speculative situation. I remain on the sidelines, seeing CNXC as a melting ice cube business with a long, uncertain path to shareholder value recovery amid ongoing AI and cost pressures. Read the full article on Seeking AlphaNarrative Update • Jun 23
CNXC: Margin Resilience And Index Shift Will Support Repriced Upside Potential
Analysts have trimmed their price targets on Concentrix by $12 to $25, citing updated assessments of the company’s outlook while keeping key assumptions such as fair value at $41.25 and long term revenue growth and profit margin broadly unchanged. Analyst Commentary Recent research on Concentrix points to a more cautious stance on valuation, with several firms trimming price targets while keeping long term growth and margin assumptions broadly intact.Narrative Update • Jun 07
CNXC: Margin Expansion And Buybacks Will Support Repriced Upside Potential
Analysts have reduced their price targets on Concentrix by $12 to $25, citing updated views on the company’s outlook. They maintained their fair value estimates and kept key model inputs such as discount rate, revenue growth, profit margin, and future P/E broadly unchanged.Narrative Update • May 13
CNXC: Margin Resilience And Buybacks Will Support Repriced Upside Potential
Concentrix's analyst price target has been revised lower by a combined $24 to $25 across several firms, with analysts citing updated views on valuation and business outlook to support the adjustment. Analyst Commentary Across the latest research updates, analysts reduced their price targets for Concentrix by amounts ranging from $12 to $25, pointing to reassessments of valuation and the business outlook.Narrative Update • Apr 25
CNXC: Margin Resilience And Buybacks Will Support Future Upside Potential
Analysts have trimmed their Concentrix price targets by $12 to $25, citing more conservative assumptions around future P/E multiples, while keeping fair value, discount rate, and margin expectations broadly unchanged. Analyst Commentary Bullish Takeaways Bullish analysts appear to see the P/E reset as a way to align expectations more closely with current sentiment, which can reduce the risk of overpaying for near term execution.Narrative Update • Apr 10
CNXC: Higher Margin Outlook And Buybacks Will Support Future Upside Potential
Narrative Update The updated analyst price target for Concentrix moves from approximately $48.60 to about $41.25. This reflects recent cuts from several firms as analysts point to more measured revenue growth assumptions, offset by slightly higher projected profit margins and a lower future P/E multiple.Narrative Update • Mar 27
CNXC: Higher Margin Outlook And Buybacks Will Support Future Undervalued Entry
The analyst price target for Concentrix has shifted from $62.20 to $48.60. Analysts attribute this change to updated assumptions around slower revenue growth, a higher profit margin profile, and a lower future P/E multiple following recent target cuts from Barrington, Baird, and Canaccord.Narrative Update • Mar 12
CNXC: AI Rollout And Buybacks Will Support Future Undervalued Entry
Analysts have trimmed their price target on Concentrix by $4, reflecting updated views captured in recent research while keeping key fair value and growth assumptions essentially unchanged. Analyst Commentary Recent research around the $4 reduction in the price target highlights a mix of confidence in Concentrix’s core thesis and a more cautious stance on execution and risk.Narrative Update • Feb 26
CNXC: Higher Discount Rate Assumptions Will Support Future Undervalued Entry
Analysts have trimmed their price target on Concentrix by $4, reflecting updated assumptions around discount rates and valuation multiples, while keeping fair value estimates for the business broadly unchanged. Analyst Commentary Analysts describe the $4 price target cut as a fine tuning of their models rather than a reset of their overall view on Concentrix, with fair value estimates broadly intact.Analysis Article • Feb 16
Benign Growth For Concentrix Corporation (NASDAQ:CNXC) Underpins Stock's 30% Plummet
Concentrix Corporation ( NASDAQ:CNXC ) shareholders won't be pleased to see that the share price has had a very rough...Narrative Update • Feb 12
CNXC: Updated Discount Rate Assumptions Will Support Future Undervalued Entry
Analysts have lowered their price target on Concentrix by $4, citing updated assumptions around discount rates and profitability, while keeping fair value estimates broadly stable. Analyst Commentary Analysts describe the recent US$4 reduction in the price target as a fine tuning of their view, reflecting updated discount rate assumptions and a more cautious stance on profitability, rather than a fundamental reset of Concentrix's underlying worth.Narrative Update • Jan 29
CNXC: Updated Discount Rate And P/E Assumptions Will Support Future Undervalued Entry
Narrative Update on Concentrix Analysts have trimmed their price target on Concentrix by $4, citing updated assumptions around discount rates and future P/E expectations, while keeping their fair value estimate unchanged at $62.20. Analyst Commentary Recent research around Concentrix reflects a mixed tone, with the $4 trim to the price target tied mainly to updated discount rate inputs and revised P/E assumptions rather than a reset of the underlying fair value, which remains at $62.20.Narrative Update • Jan 15
CNXC: Higher Discount Rate Reset Will Support Future Undervalued Entry Thesis
Analysts have trimmed their price target on Concentrix by about $2.63, citing updated assumptions on fair value, discount rate, revenue growth, profit margin and future P/E following recent research that included a $4 reduction highlighted at Baird. Analyst Commentary Analysts framing the new price target are trying to line up their fair value work with updated assumptions on discount rates, revenue growth, margins and the future P/E they think the market is willing to pay for Concentrix.Analysis Article • Nov 08
Concentrix Corporation (NASDAQ:CNXC) Not Doing Enough For Some Investors As Its Shares Slump 28%
The Concentrix Corporation ( NASDAQ:CNXC ) share price has fared very poorly over the last month, falling by a...Analysis Article • Sep 29
Concentrix's (NASDAQ:CNXC) Upcoming Dividend Will Be Larger Than Last Year's
The board of Concentrix Corporation ( NASDAQ:CNXC ) has announced that it will be paying its dividend of $0.36 on the...Narrative Update • Sep 27
AI Integration And Webhelp Synergies Will Transform Business
Concentrix's consensus price target was modestly reduced to $64.83 as analysts factor in compressed valuation multiples from AI-related investor uncertainty and secular headwinds—rather than fundamental weakness—while maintaining confidence in growth reacceleration and strong business fundamentals. Analyst Commentary Compressed valuation multiples attributed to investor uncertainty over the impact of artificial intelligence on labor-intensive business models and broader secular headwinds, not due to fundamental company weakness.Analysis Article • Apr 03
Concentrix Corporation's (NASDAQ:CNXC) Shares Leap 26% Yet They're Still Not Telling The Full Story
The Concentrix Corporation ( NASDAQ:CNXC ) share price has done very well over the last month, posting an excellent...Analysis Article • Jan 29
The Market Lifts Concentrix Corporation (NASDAQ:CNXC) Shares 25% But It Can Do More
Concentrix Corporation ( NASDAQ:CNXC ) shareholders have had their patience rewarded with a 25% share price jump in the...Seeking Alpha • Jan 17
Concentrix: Better Than Expected Results, GenAI, And Cheap
Summary Concentrix Corporation delivered better-than-expected EPS and revenue, driven by significant investments in its GenAI product suite and a booming AI customer experience market. The AI in customer experience market is projected to grow at a 22% CAGR, potentially boosting CNXC's future revenue and free cash flow growth. Despite risks from high debt levels and potential global tariffs, CNXC's substantial headcount growth and consistent net income make it appear undervalued. My financial model suggests CNXC is significantly undervalued, with an equity valuation of $6.5 billion and a target price of $102 per share. Read the full article on Seeking AlphaSeeking Alpha • Dec 21
AI: Will Freshworks Leave Room For Concentrix?
Summary A.I. is revolutionising Customer Relationship Management (CRM), with Salesforce leading the market, leveraging Big Data to enhance customer interactions and sales conversions. Generative A.I. significantly boosts Customer Experience (CX) performance, with early adopters seeing a 25% increase in CX satisfaction, and the global CX market projected to grow to $33bn by 2030. Concentrix, with a $2.86bn market cap, offers comprehensive CX services including call centres. Freshworks is a SAAS only CX provider. Both companies have seen 70% plus share price declines, but one is still priced for growth, the other for business declines. Is this justified? Read the full article on Seeking AlphaSeeking Alpha • Nov 01
Concentrix: Significant Business Growth Driven By AI, And Cheap Valuation
Summary Concentrix's diversified client base, strong cash flow, and expanding AI-driven services make it a compelling buy at the current stock price. The company’s global presence and technological innovations in data analytics and AI are expected to drive future revenue and profitability growth. Concentrix's efficient debt management and significant undervaluation compared to peers suggest substantial upside potential. Despite potential risks from technological failures and client concentration, the company looks like a buy. Read the full article on Seeking AlphaAnalysis Article • Oct 22
Positive Sentiment Still Eludes Concentrix Corporation (NASDAQ:CNXC) Following 26% Share Price Slump
The Concentrix Corporation ( NASDAQ:CNXC ) share price has fared very poorly over the last month, falling by a...Financial Position Analysis
Short Term Liabilities: CNXC's short term assets ($3.0B) exceed its short term liabilities ($2.6B).
Long Term Liabilities: CNXC's short term assets ($3.0B) do not cover its long term liabilities ($5.2B).
Debt to Equity History and Analysis
Debt Level: CNXC's net debt to equity ratio (160.3%) is considered high.
Reducing Debt: CNXC's debt to equity ratio has increased from 37.9% to 169.7% over the past 5 years.
Debt Coverage: CNXC's debt is not well covered by operating cash flow (16.2%).
Interest Coverage: CNXC's interest payments on its debt are not well covered by EBIT (2.2x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/07/15 21:45 |
| End of Day Share Price | 2026/07/15 00:00 |
| Earnings | 2026/05/31 |
| Annual Earnings | 2025/11/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Concentrix Corporation is covered by 5 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| David Koning | Baird |
| Vincent Colicchio | Barrington Research Associates, Inc. |
| Ruplu Bhattacharya | BofA Global Research |